Liquid Biopsy 2018 Global Market Net Worth $ 5 Billion USD Forecast By 2023
With constant advancements in medical field in respect of technology and treatments, cancer tests have become more personalised and advanced. A similar boom is underway to speed up and improve the detection of cancers, known as Liquid Biopsy, an emerging group of technologies which holds the promise to revolutionize cancer diagnostics and treatment. Its wide applicability has sparked off a lot of interest among researchers and commercial players.
According to researcher new research report “Global Liquid Biopsy Market Outlook to 2023”, the global liquid biopsy market is projected to cross the US$ 5 Billion mark by the end of 2023. A number of factors such as growing public and private funding to support research activities in the field of liquid biopsy, rising preference by oncologists for liquid biopsy, growing number of product launches to support development and increasing adoption of personalised medicine is driving the growth of this market.
Get a Sample Report @ https://www.wiseguyreports.com/sample-request/2769071-global-liquid-biopsy-market-outlook-to-2023
For more information or any query mail at email@example.com
In this report, a major focus has been on the development of innovative products based on different application, technology and different sample types. In this context, the study provides present and future outlooks for the two broad categories of liquid biopsy market; by analyte and by sample type. The former comprises of the three marker categories that dominate liquid biopsy today: circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (or exosomes). On the other hand, the latter includes the two major bodily fluid samples: blood and urine. According to report, blood is the most widely used sample type and is expected to remain the largest market based on sample type in the coming years as well.
The report also includes a detailed analysis of commercialized liquid biopsy products. A handful of companies are currently marketing liquid biopsies, but commercial applications remain largely limited to therapy selection, and treatment monitoring. A detailed pipeline analysis of upcoming liquid biopsy products has also been conducted. Most of the current research is focused on utilizing liquid biopsy for diagnostic purposes such as response evaluation, expression profiling, tumor diagnosis, and treatment monitoring in a blood test.
The market has been divided into four major geographic regions: North America, Europe, Asia, and Rest of the World. North America is the largest market for the liquid biopsy industry. This high share is attributed to the relatively high adoption rate of liquid biopsy coupled with launch of new and advanced products in the market. The Asian market is poised to witness the highest growth owing to increasing focus of players in this region.
in its report, further covers how major trends and drivers, mainly therapy selection, increasing use of circulating tumor cells for cancer screening, growing interest of venture capital firms etc., will propel the industry’s growth. An analysis has also been done of a few factors limiting the growth of the industry.
After an exhaustive study of the industry, RNCOS has laid out the primary market players that are engaged in providing liquid biopsy–based tools and services. These players are working over a vast variety of products such as blood-based tests, urine-based tests, assays and instruments for sample extraction, amplification and purification, and constantly upgrading their portfolio to keep up with the latest developments in the field. Some of these players include QIAGEN NV, Roche Diagnostics, Foundation Medicine, Trovagene, Guardant Health, and Biocept.
Overall, even though the market is in its nascent stage at the moment, it is expanding at an almost exponential rate. With new players entering the market, increase in the number of collaborations and strong support from research institutes, the liquid biopsy market is bound to witness rampant diversification and growth in the coming years.
Ask Query @ https://www.wiseguyreports.com/enquiry/2769071-global-liquid-biopsy-market-outlook-to-2023
Table Of Contents – Major Key Points
1. Analyst View
2. Research Methodology
3. Liquid Biopsy: An Introduction
4. Market Dynamics
4.1 Market Drivers
4.1.1 High Prevalence of Cancer
4.1.2 Technological Advancements in Personalized Therapies
4.1.3 Increasing Demand for Minimally Invasive Biopsy Techniques
4.1.4 Low Cost
4.1.5 Growing Interest of Venture Capital Firms
4.2 Market Restraints
4.2.1 A Less-Defined Regulatory Environment
4.2.2 Comparatively Low Concentration of Molecular Biomarkers in Body Fluids
4.2.3 Need for Proper Handling and Storage of the Samples
4.3 Market Opportunities
4.3.1 Use of Urine Sample May Witness a Paradigm Shift in Screening and Monitoring Practices
4.3.2 Exosomes Offer Great Advantages as Source Materials
4.3.3 Next-Generation Sequencing Offers Significant Opportunity
4.3.4 Prenatal Screening and Organ Transplantation: Upcoming Applications
4.4 Industry Trends
4.4.1 Circulating Tumor Cells: Gaining Potential in Liquid Biopsy
4.4.2 Blood: The Most Widely Used Sample
5. Global Liquid Biopsy Market Outlook to 2023
6. Commercially Developed Liquid Biopsy Tests
7. Global Liquid Biopsy Market Size by Technology
7.1 Circulating Tumor Cells (CTCs)
7.2 Circulating Tumor DNA (ctDNA)
8. Global Liquid Biopsy Market Size by Sample Type
8.3 Other Fluids
9. Global Liquid Biopsy Market Size by Geography
9.1 North America
9.4 Rest of the World (RoW)
10. Pipeline Analysis
11. Key Player Analysis
11.1 Personal Genome Diagnostics
11.2 Guardant Health, Inc.
11.3 Pathway Genomics
11.4 RainDance Technologies
11.5 Trovagene, Inc.
11.6 Cynvenio Biosystems, Inc.
11.7 Biocept, Inc.
11.8 ANGLE plc
11.10 Clearbridge BioMedics Pte Ltd
11.11 Exosome Diagnostics, Inc.
11.12 Foundation Medicine, Inc.
11.13 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
11.14 Genomic Health
11.15 Myriad Genetics, Inc.
11.16 Thermo Fisher Scientific, Inc.
11.17 QIAGEN NV
11.18 Bio-Rad Laboratories, Inc.
12. The Future of Liquid Biopsy
Buy 1-User PDF @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2769071
For more information or any query mail at firstname.lastname@example.org
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.
Office No.528,Amanora Chambers,Magarpatta Road,Hadapsar,Pune-411028.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liquid Biopsy 2018 Global Market Net Worth $ 5 Billion USD Forecast By 2023 here
News-ID: 896076 • Views: 280
More Releases from WiseGuy Research Consultants Pvt. Ltd.
Surveillance 2018 Global Market Net Worth US$ 43600 million Forecast By 2022
WiseGuyReports.Com Publish a New Market Research Report On –“ Surveillance 2018 Global Market Net Worth US$ 43600 million Forecast By 2022”. Description: The Surveillance industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Surveillance market size to maintain the average annual growth rate of 11.54% from 17980 million $ in 2014 to 24950 million $ in 2017, The analysts believe that in the
Tunnel Boring Machine (TBM) Market 2018 Global Analysis By Key Players – Herre …
WiseGuyReports.Com Publish a New Market Research Report On –“ Tunnel Boring Machine (TBM) Market 2018 Global Analysis By Key Players – Herrenknecht, CRTG, CRCHI, Robbins, Tianhe, Komatsu, Mitsubishi”. Description: The Tunnel Boring Machine (TBM) industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Tunnel Boring Machine (TBM) market size to maintain the average annual growth rate of 7.11% from 1880 million $ in
Ultra Fine Copper Powder 2018 Global Market Net Worth US$ 405 million Forecast B …
WiseGuyReports.Com Publish a New Market Research Report On –“ Ultra Fine Copper Powder 2018 Global Market Net Worth US$ 405 million Forecast By 2022”. Description: The Ultra Fine Copper Powder industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Ultra Fine Copper Powder market size to maintain the average annual growth rate of 5.27% from 270 million $ in 2014 to 315 million
Car Leasing Market 2018 Global Share,Trend,Segmentation and Forecast to 2022
WiseGuyReports.Com Publish a New Market Research Report On –“ Car Leasing Market 2018 Global Share,Trend,Segmentation and Forecast to 2022”. Description: The Car Leasing industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Car Leasing market size to maintain the average annual growth rate of X% from XXXX million $ in 2013 to XXXX million $ in 2016, The analysts believe that in the
More Releases for Biopsy
Biopsy Devices Market Overview by Breast Biopsy, Lung Biopsy, Prostate Biopsy to …
Download Free PDF Sample Papers Now at Biopsy Devices Market https://www.reportsnreports.com/contacts/requestsample.aspx?name=1159148 . Biopsy devices market report analyzes various types of biopsy devices in market and their adoption patterns. It aims at estimating market size and future growth potential of biopsy devices market for different segments such as product, guidance technique, application, end user, and region. Global biopsy devices market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East
Biopsy Device Market to Increase to US$ 2,621 Mn by 2026 | Guidance System (Ster …
Key players focussing on strategic M&A for amplified market shares Patients are increasingly preferring minimally invasive surgical procedures in order to avoid conventional surgical complications and side-effects, promoting sales of biopsy devices, leading to the growth of the biopsy devices globally. In addition to enabling the accurate diagnosis, a biopsy device assures minimal patient discomfort and trauma. This is identified to be a major factor impacting the popularity of biopsy, and
Breast Biopsy Market Report 2018: Segmentation by Product (Vacuum Assisted Biops …
Global Breast Biopsy market research report provides company profile for Hologic Inc., Leica Biosystems Nussloch GmbH (Devicor Medical Products, Inc.), C. R. Bard, Inc., Becton and Dickinson Company, Argon Medical Devices, Cook Medical Incorporated, Encapsule medical Devices LLC. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume,
Biopsy Devices Market Report 2018: Segmentation by Product (Core Needle Biopsy, …
Global Biopsy Devices market research report provides company profile for C. R. Bard, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Cook Group Incorporated (U.S.), Devicor Medical Products, Inc., (Leica Biosystems) (Germany), Argon Medical Devices (U.S.) and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Needle Biopsy Industry 2018, Market Structure - By Type Fine-Needle Aspiration B …
Needle Biopsy Market information: by type (fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy, image-guided biopsy) by utility (disposable, reusable), by applications (tumor, infection, Inflammation, others) - Global Forecast till 2023. Considering all these factors the market for Needle Biopsy is expected to reach $ 677 million by the end of 2023, this market is projected to be growing at a CAGR of ~ 5.2 % during 2017-2023. KEY PLAYERS OF NEEDLE
Global Breast Biopsy Devices Market In Japan: By Product - Biopsy Needles, Biops …
Researchmoz added Most up-to-date research on "Global Breast Biopsy Devices Market In Japan: By Product - Biopsy Needles, Biopsy Tables, Guidance Systems & Localization Wires" to its huge collection of research reports. The global Breast Biopsy Devices market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2017, growing at a CAGR of XX% between 2016 and 2022. Japan plays an